Primary central nervous system lymphoma is a rare, aggressive brain tumor that originates from immune cells, mainly affecting the brain, spinal cord, or eye with no involvement of lymph nodes.
Hyperbaric oxygen therapy may boost the effectiveness of chemotherapy, radiation, and immunotherapy treatments for primary central nervous system lymphoma, consequently improving patient outcomes.